Oxygen in Medical Technology
Navigation Links
Oxygen in Medical Technology
FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
... System experienced fewer and less significant oxygen desaturation events, a clinical sign of ... of critical patient vital signs, including oxygen saturation, respiratory rate, heart rate, blood ... or reducing delivery of propofol, increasing oxygen delivery and automatically instructing patients ...... hypoxemia-a potentially life-threatening lack of oxygen in the blood-in children with sickle cell ... red blood cells that compromise vital blood and oxygen supply to the tissues and organs, causing ... in a sickle cell patient's blood reduces oxygen supply further because these dyshemoglobins that ...
... it may not initiate a clinical trial of Biopure's oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- ... manufactures and markets pharmaceuticals, called oxygen therapeutics that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin ...
... to conduct a clinical trial of the company's oxygen therapeutic Hemopure(R) [hemoglobin glutamer - ... manufactures and markets pharmaceuticals, called oxygen therapeutics that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin ...
... MESA, Calif., March 19 /PRNewswire-FirstCall/ -- oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) ... the company's perfluorocarbon (PFC) therapeutic oxygen carrier. The letter was in response to the ... the needs of all our stakeholders." About oxygen Biotherapeutics, Inc. ...
Oridion Announces Significant Medical Studies Presented at STA
... dioxide (EtC02), Respiratory Rate, Pulse Rate and oxygen saturation (SpO2) to provide a clear ... other tested CO2 sampling lines with and without oxygen supply, when sampling from nose and mouth ... to assessing the interactions of heart rate, oxygen saturation, respiratory rate and adequacy of ...... to conduct a clinical trial of the company's oxygen therapeutic Hemopure(R) [hemoglobin glutamer - ... manufactures and markets pharmaceuticals, called oxygen therapeutics that are intravenously administered ... glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the ...
Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
... for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells ... in 1932 and Leland Clark invented the Clark oxygen electrode in 1959. "Without oxygen consumption measurements, the study of ...Battelle Scientists Named on Patent for Making Oxygen From Light and Water
... from Battelle has earned a patent for generating oxygen in a process that mimics photosynthesis. The technology creates oxygen and controls carbon dioxide using light energy ... and electrons from water and makes molecular oxygen without producing hydrogen gas. Then, the protons ...... to the treatment of conditions characterized by oxygen deprivation (hypoxia) at the cellular level. ... of action, TSC enhances the diffusion of oxygen through blood plasma, increasing the rate of oxygen transport and thus treating the symptoms of ...
... of 160 F. The color of meat depends on the oxygen in the muscle cells, Hunt said. As an example, he ... oxygen, which causes the color to change. The oxygen in the muscle is carried by myoglobin, which is similar to hemoglobin that carries oxygen in humans. Observations during the study ...
Biopure Announces Meeting With FDA
... Biopure CEO and President. "By serving as an oxygen delivery bridge following chemotherapy-induced ... manufactures and markets pharmaceuticals, called oxygen therapeutics that are intravenously administered ... glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the ...Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
... the crossover patients had a greater need for an oxygen carrier, likely related to patient age, volume ... manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered ... glutamer - 200 bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the ...... System experienced fewer and less significant oxygen desaturation events, a clinical sign of over ... primary endpoint of Area Under the Curve (AUC) of oxygen desaturation (SpO2 < 90%). AUC is an ... incorporates incidence, duration and depth of oxygen desaturation. Patients in the SEDASYS(TM) System ...
Biopure Announces Publication of Phase II Proof-of-Concept Coronary Trial
... trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary ... this trial, we believe that Hemopure could be an oxygen bridge to prevent permanent myocardial damage ... in an acute setting, HBOC-201 could serve as an oxygen bridge to reperfusion by percutaneous coronary ...... coronary arteries. The temporary absence of oxygen and nutrients from blood creates a condition in ... stress, caused by the production of reactive oxygen species. Reperfusion injury is due in part to the ... damage. The restored blood flow reintroduces oxygen within cells that damages cellular proteins, DNA, ...
Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
... demand for a safe and effective agent to improve oxygen transport in clinical settings where blood is ... to be completed in the near future. No similar oxygen transport agents are currently on the market ... clinical studies indicate that Hemospan's novel oxygen delivery mechanism has the potential to provide ...... research, development and commercialization of oxygen transport agents, today announced that ... CEO of Sangart. Hemospan is a hemoglobin-based oxygen transport agent designed to serve as an oxygen therapeutic and as an alternative to blood ...
... total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM)) as part of the Rainbow SET ... in Toronto, Canada, said, "Accurate monitoring of oxygen saturations in children with cyanotic congenital ... noninvasive total hemoglobin (SpHb) and oxygen content (SpOC) as part of the Rainbow ...
Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
... of recent clinical studies indicating their oxygen colon cleanser is extremely successful at ... failure rate. Colon cleansing with an oxygen colon cleanser is likely to become the new ... CEO and head of product development, says using oxygen to colon cleanse is the best thing a person can ...Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
... research, development and commercialization of oxygen transport agents, announced today that it ... CEO of Sangart. Hemospan is a hemoglobin-based oxygen transport agent designed to serve as an oxygen therapeutic and as an alternative to blood ...New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
... blood flow, muscle oxygen supply HOBOKEN, N.J., Oct. 17 /PRNewswire/ -- A ... which leads to an increase in blood flow and oxygen supply to muscles. Nitric oxide, a key ... flow that serves to deliver more nutrients and oxygen to the muscles, helping muscles to cope with ...Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
... a new application and drug dosage of hyperbaric oxygen therapy. Hyperbaric oxygen therapy has been applied to diving injuries, ... Orleans, and author of recently published The oxygen Revolution (Hatherleigh Press, NY), said that he ...Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
... know that islets require a high amount of oxygen for optimal health, so UM researchers created a ... provide the cells with a more natural oxygen environment than those used in traditional ... stem cells, we were able to show that delivering oxygen in a physiological way enhanced enormously ...Biopure Announces 2007 Third Quarter Financial Results
... Phase 2 out-of-hospital trauma study of Biopure's oxygen therapeutic Hemopure. In a recent letter to the ... function and/or wound healing by transporting oxygen through constricted or partially blocked arteries ... manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered ...... including: noninvasive and continuous total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), ... SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), ...
... and that this risk is higher among infants exposed to supplemental oxygen or assisted ventilation during the neonatal period. These findings were ... characteristics evaluated included GA, infant sex, "small for GA" status, oxygen exposure variables, and hospital discharge during the RSV season. The ...
... which is a composite endpoint comprised of normalization of temperature, oxygen saturation, respiratory rate, systolic blood pressure and heart rate. ... chronic lung disease, congestive heart failure, diabetes mellitus, low oxygen saturation, low blood pressure, or severity of illness requiring ...
Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
... death in the U.S., stroke is called a brain attack because blood flow and oxygen to part of the brain is cut off. About 85 percent of strokes are ischemic, ... and are caused by a broken blood vessel. The lack of blood flow and oxygen to the site of the stroke causes the brain tissue to die. About a quarter ...Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
... activity (i.e., higher levels of oxidized lipids promote the creation of oxygen free radicals and reactive oxygen species (ROS), such as H2O2, which can promote inflammation). As ...... process for early signs of hypotension, apnea, airway obstruction, and/or oxygen desaturation. Facilities for providing cardiopulmonary resuscitation must ... minutes in bronchoscopy patients. The use of supplemental oxygen is recommended in all patients receiving LUSEDRA. Airway assistance ...
... determined that low hemoglobin saturation (a decrease in the amount of oxygen in the blood) may predispose children with sickle cell disease to having a stroke by limiting oxygen delivery to the brain. Since hemoglobin saturation can be easily measured, ...
... molecule of LS11 many times, resulting in a continuous supply of singlet oxygen molecules. The Litx device contains a tiny array of LEDs at the ... closes tumor blood supply vessels, starving remaining cancer cells of oxygen and nutrients. The use of multiple light sources and multiple treatments ...
... loss? One possibility is that in reducing metabolism, H2S also reduces oxygen demand, which allows crucial neurons in the hippocampus, the part of the ... autonomic functions such as breathing and heartbeat, to withstand low oxygen levels due to hemorrhage. Another mechanism may be that hydrogen ...
U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R)
... Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics that are intravenously administered to deliver oxygen to the ... Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug ...Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
... technology. Oxygent is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients. Except for historical information, the ...... someone dies of one. A stroke occurs when a blood vessel that carries oxygen and nutrients to the brain becomes blocked by a blood clot (ischemic stroke) or ruptures (hemorrhagic stroke). This interruption in the blood and oxygen supply, to part of the brain, results in cell death and loss of function. ...
Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
... proprietary PFC technology. Oxygent is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients. Except for historical information, the ...... p eroxidase J. Timothy Greenamyre, MD, PhD, University of Pittsburgh Validation of Nox1/Rac1, a novel molecular source of reactive oxygen species in the nigrostriatal pathway, as a target for Parkinson ' s disease therapy Yoon-Seong Kim, MD, PhD, Weill Medical College of Cornell ...
... This product is designed to increase nitric oxide levels in the body causing a hemodilation effect which expands blood vessels, allowing more blood, oxygen and nutrients to flow to muscles. "This is truly groundbreaking research that has resulted in the delivery of a truly novel and ...
Other ContentsexclusionexclusionexclusionexclusionexclusioncompetitivecompetitivecompetitivecompetitivecompetitivecompetitivebioinformaticsbioinformaticsbioinformaticsbioinformaticsbioinformaticsbioinformaticscrossovercrossovercrossovercrossovercrossoverchromosomalchromosomalchromosomalchromosomalchromosomalchromosomalOther TagsRotatorPracticePracticePractice
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Grooving down the helix 2Grooving down the helix 3Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 1Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference 53950 2Highest ever winter water temperatures recorded 9516 1Highest ever winter water temperatures recorded 9516 2NIH stimulus funding supports Emory biomedical scientists 9512 1NIH stimulus funding supports Emory biomedical scientists 9512 2NIH stimulus funding supports Emory biomedical scientists 9512 3NIH stimulus funding supports Emory biomedical scientists 9512 4(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2[0] Distributor Announces New Applications for Wind Turbines [0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist[0] Potential new 'twist' in breast cancer detection[0] Timing of Multiple-Ligament Knee Surgery May Not Matter
BioTwistUltraSorbTwinfixTACITFASTINKnotlessRotatorProxisAtakrUltraFixPrimeSuitePrimeChartNextGenPractice
Other Tagsskipping 2studying 2studying 3studying 4studying 5studying 6studying 7studying 8studying 9studying 10| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |